Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Change in Account Payables (2016 - 2022)

RedHill Biopharma has reported Change in Account Payables over the past 7 years, most recently at -$554000.0 for Q4 2022.

  • Quarterly Change in Account Payables rose 84.53% to -$554000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$7.4 million through Dec 2022, down 6797.3% year-over-year, with the annual reading at -$437000.0 for FY2025, 79.29% up from the prior year.
  • Change in Account Payables was -$554000.0 for Q4 2022 at RedHill Biopharma, down from $411000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.8 million in Q2 2021 and troughed at -$6.0 million in Q1 2022.
  • The 5-year median for Change in Account Payables is -$52500.0 (2018), against an average of -$28750.0.
  • Year-over-year, Change in Account Payables tumbled 5235.9% in 2018 and then soared 2372.55% in 2020.
  • A 5-year view of Change in Account Payables shows it stood at -$543000.0 in 2018, then dropped by 12.34% to -$610000.0 in 2019, then surged by 917.05% to $5.0 million in 2020, then plummeted by 171.85% to -$3.6 million in 2021, then soared by 84.53% to -$554000.0 in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Change in Account Payables are -$554000.0 (Q4 2022), $411000.0 (Q3 2022), and -$1.3 million (Q2 2022).